China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers
China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthChina's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers
View Premium plansBrowse free archive reportsChina's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers.